These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 1329195

  • 1. [Platelet-activating factor antagonists and asthma].
    Wang YY, Li CL.
    Sheng Li Ke Xue Jin Zhan; 1992 Apr; 23(2):136-40. PubMed ID: 1329195
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [The significance of platelet activating factor and its antagonists in bronchial asthma].
    Beume R, Kilian U.
    Med Klin (Munich); 1989 Jun 15; 84(6):286-93. PubMed ID: 2547143
    [No Abstract] [Full Text] [Related]

  • 4. Recent development of platelet-activating factor antagonists.
    Shen TY, Hussaini I, Hwang SB, Chang MN.
    Adv Prostaglandin Thromboxane Leukot Res; 1989 Jun 15; 19():359-62. PubMed ID: 2546389
    [No Abstract] [Full Text] [Related]

  • 5. [Function of platelet activating factor in asthma].
    Ukena D, Sybrecht GW.
    Dtsch Med Wochenschr; 1988 Oct 21; 113(42):1651-6. PubMed ID: 2846251
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Interspecies scaling of a thienodiazepine platelet-activating factor receptor antagonist.
    Elder CA, Modi MW.
    Drug Metab Dispos; 1995 Jul 21; 23(7):776-8. PubMed ID: 7587967
    [No Abstract] [Full Text] [Related]

  • 8. Platelet-activating factor antagonists: scientific background and possible clinical applications.
    Koltai M, Guinot P, Hosford D, Braquet PG.
    Adv Pharmacol; 1994 Jul 21; 28():81-167. PubMed ID: 8080821
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Platelet activating factor receptor occupancy in relation to activation and desensitization of phosphoinositide specific phospholipase C.
    Shukla SD, Morrison WJ.
    Prog Clin Biol Res; 1988 Jul 21; 283():341-4. PubMed ID: 2850576
    [No Abstract] [Full Text] [Related]

  • 13. Chemistry and pharmacology of PAF antagonists. Evaluation of changes at potential metabolism sites on activity and duration of activity.
    Handley DA, Houlihan WJ, Tomesch JC, Farley C, Deacon RW, Koletar JM, Prashad M, Hughes JW, Jaeggi C.
    Adv Prostaglandin Thromboxane Leukot Res; 1989 Jul 21; 19():367-70. PubMed ID: 2546390
    [No Abstract] [Full Text] [Related]

  • 14. Platelet-activating factor-binding protein in human serum.
    Matsumoto M, Miwa M.
    Adv Prostaglandin Thromboxane Leukot Res; 1985 Jul 21; 15():705-6. PubMed ID: 3004155
    [Abstract] [Full Text] [Related]

  • 15. Functional validation of platelet-activating factor receptor sites characterized biochemically by a specific and reproducible [3H]platelet-activating factor binding in human platelets.
    Tahraoui L, Floch A, Cavero I.
    J Pharmacol Exp Ther; 1990 Mar 21; 252(3):1221-7. PubMed ID: 2156995
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The role of platelet activating factor and its antagonists in shock, sepsis and multiple organ failure.
    Anderson BO, Bensard DD, Harken AH.
    Surg Gynecol Obstet; 1991 May 21; 172(5):415-24. PubMed ID: 1851337
    [Abstract] [Full Text] [Related]

  • 19. Beneficial effects of (RS)-2-methoxy-3-(octadecylcarbamoyloxy)propyl 2-(3-thiazolio)ethyl phosphate, a specific PAF antagonist, in endotoxin and anaphylactic shock.
    Terashita Z, Imura Y, Nishikawa K, Sumida S.
    Adv Prostaglandin Thromboxane Leukot Res; 1985 May 21; 15():715-7. PubMed ID: 3004156
    [No Abstract] [Full Text] [Related]

  • 20. The platelet activating factor receptor antagonist, RP 59227, blocks platelet activating factor receptors mediating liberation of reactive oxygen species in guinea pig macrophages and human polymorphonuclear leukocytes.
    Floch A, Tahraoui L, Sedivy P, Cavero I.
    J Pharmacol Exp Ther; 1991 Aug 21; 258(2):567-75. PubMed ID: 1650834
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.